Synonyms: AN3365 | BRII-658 | GSK2251052
Compound class:
Synthetic organic
Comment: Epetraborole (GSK2251052) is an aminomethylbenzoxaborole antibacterial compound that is an inhibitor of bacterial leucyl-tRNA synthetase (LeuRS) [2]. It is being developed for the treatment of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
|
|
Bioactivity Comments |
Epetraborole has activity in vitro against multidrug-resistant Gram-negative bacteria spp., including Pseudomonas aeruginosa (MIC90 of 1-4 μg/ml) and Enterobacteriaceae bearing NDM-1 and KPC carbapenemases (MIC90 of 0.5-2μg/ml) [2]. Epetraborole also demonstrates activity against Mycobacterium abscessus both in vitro (MIC of 0.28-0.56 μM) and in a mouse model of M. abscessus infection [1]. |